ChronoScale Holdings expands AI infrastructure contracts, eyes $1 billion revenue run rate by 2027

ChronoScale Holdings secures expanded AI infrastructure contracts

ChronoScale Holdings (NASDAQ:CHRN) announced Wednesday it has expanded an agreement with an existing AI infrastructure customer and signed a separate contract with a new customer, significantly increasing its contracted deployment pipeline1

1

2

2

. These agreements position the company to achieve a $1 billion revenue run rate by the third quarter of 2027, representing a substantial milestone for the GPU-based AI training and high-performance computing provider.

Cenly Chen, Chief Executive Officer of ChronoScale Holdings, emphasized the significance of these developments: "We view the expansion of this existing customer relationship and the onboarding of the new customer as an important validation of both the demand we are seeing and our ability to grow alongside our customers"2

2

. The expanded AI infrastructure contracts demonstrate growing market demand for specialized computing resources that support AI training, AI inference, and other compute-intensive applications.

Revenue projections tied to infrastructure deployment milestones

The projected $1 billion revenue run rate remains contingent on several operational factors. ChronoScale noted that reaching this target depends on timely infrastructure deployment and commissioning, power and equipment availability, and access to capital on acceptable terms1

1

2

2

. The company calculates its annualized revenue run rate by multiplying revenue recognized under contracts in a quarterly period by four, based on current assumptions rather than forecasted revenue for specific reporting periods.

These dependencies highlight the operational complexities inherent in scaling AI infrastructure operations. Power availability has become a critical bottleneck for data center expansion, particularly for facilities housing GPU clusters that consume substantial electricity. Equipment availability also presents challenges as demand for advanced GPUs continues to outpace supply across the industry. Watch how ChronoScale navigates these infrastructure constraints as deployment timelines progress through 2027.

Strategic focus sharpens with Ekso Bionics divestiture

ChronoScale completed the sale of its Ekso Bionics business unit to Wandercraft, though financial terms were not disclosed1

1

2

2

. The divestiture allows ChronoScale to concentrate resources exclusively on GPU-based infrastructure for AI training, inference, and high-performance computing. Chen stated the transaction would "further sharpen our focus and concentrate our resources on what we see as the significant opportunity ahead in AI infrastructure"1

1

.

This strategic shift reflects broader industry trends where companies are divesting non-core assets to capitalize on surging demand for AI infrastructure. ChronoScale was formed through a combination of Applied Digital's cloud business and EKSO Bionics Holdings, Inc.2

2

. By shedding the Ekso Bionics medical robotics division, the company can allocate capital and management attention toward scaling its core AI infrastructure operations.

Stock performance and analyst outlook signal market confidence

CHRN shares rose following the announcement, trading at $19.70 on Friday, up 1.76% at the time of publication1

1

. The stock performance reflects investor optimism about the company's growth trajectory in the AI infrastructure market. ChronoScale carries a Strong Buy analyst consensus rating with an average price forecast of $321

1

. Northland Capital Markets initiated coverage on September 18 with an Outperform rating and a $32 price target.

Technical indicators show the stock trading above its 20-day simple moving average of $19.81 and 100-day SMA of $20.26, though it remains below the 50-day SMA of $20.661

1

. The Relative Strength Index stands at 45.04, indicating neutral momentum with room for additional upside. Key resistance sits at $22.50, while support holds at $17.00. The market will be watching whether ChronoScale can execute on its deployment schedule and convert contracted pipeline into recognized revenue as it works toward the 2027 target.